QNRX — Quoin Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Cellect Biotech skyrockets after receiving 'intention to grant' patents
Brief: Cellect Biotechnology Receives "Intention To Grant" Patents From European And Israeli Patent Offices
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Intra-Cellular, Cassava Sciences
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Intra-Cellular Therapies, Seadrill
U.S. STOCKS ON THE MOVE-Apache Corp, Cincinnati Bell, Seadrill, Intra-Cellular Therapies
Cellect Biotechnology: Rises after co receives approval for U.S. clinical trial
Brief: Cellect Biotechnology Receives Approval For U.S. Clinical Trial
Brief: Cellect Biotechnology Ltd Posts Quarterly Loss Per ADS Of NIS 0.42
Brief: Cellect Biotechnology Posts Qtrly Net Loss $0.01 Per Share And $0.12 Per Ads
Brief: Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Cellect Biotechnology - Got Ind Application From FDA To Start Trial For Apograft Technology For Haploidentical Bone Marrow Transplantations
U.S. STOCKS ON THE MOVE-Twitter, Tesla, PayPal, EBay
U.S. STOCKS ON THE MOVE-Aircastle, Twitter, OpGen, Tesla
U.S. STOCKS ON THE MOVE-Twitter, Tesla, OpGen, PayPal
Brief: Cellect Biotechnology Reports Quarterly Loss Per Ads $0.08
U.S. STOCKS ON THE MOVE-CannTrust, Cellect, Barrick Gold
Cellect Biotechnology: Surges on positive recommendation from safety review committee
Brief: Cellect Biotechnology Announces Positive Outcome From Safety Review Committee
Brief: Cellect Biotechnology, Washington University Finalize Accelerated Clinical Trial Agreement